Literature DB >> 19288406

Cytotoxic properties of root extract and fruit juice of Trichosanthes cucumerina.

Sumonthip Kongtun1, Weena Jiratchariyakul, Tanawan Kummalue, Peerapan Tan-ariya, Somyos Kunnachak, August Wilhelm Frahm.   

Abstract

The root extract of Trichosanthes cucumerina L. and bryonolic acid (1), its main constituent, as well as the fruit juice and cucurbitacin B (3), its main constituent, were tested for cytotoxicity against four human breast cancer cell lines (SKBR3, MCF7, T47D, and MDA-MB435), two lung cancer cell lines (A549 and SK-LU1), and one colon cancer cell line (Caco-2). The root extract had higher IC (50) values than bryonolic acid (1) against three breast cancer cell lines (MCF7 = 267/121, T47D = 316/124, MDA-MB435 = 140/90 microL/mL) and one lung cancer cell line (A549 = 106/100 microL/mL). The fruit juice also had higher IC (50) values than cucurbitacin B (3) against the four breast cancer cell lines (131/73, 375/35, 249/60, and 156/26 microL/mL, respectively) and one lung cancer cell line (141/41 microL/mL) as shown above, as well as against the colon cancer cell line (101/1.5 microL/mL). However, the root extract inhibited SK-LU1 more strongly than did the fruit juice, cucurbitacin B (3), and bryonolic acid (1) (149/169/180/>500 microL/mL, respectively). The root extract inhibited the two lung and three breast cancer cell lines (SKBR3, MDA-MB435, and MCF7) more strongly than the fruit juice. Bryonolic acid (1) inhibited MDA-MB435 somewhat better than the other tested human cancer cell lines. The fruit juice inhibited the colon cancer cell line (Caco-2) more strongly than the root extract. Cucurbitacin (3) inhibited human cancer cell lines, especially Caco-2, much more strongly than bryonolic acid (1). In addition to bryonolic acid (1), bryononic acid (2), cucurbitacin B (3), and dihydrocucurbitacin B (4) also were isolated from the root extract.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288406     DOI: 10.1055/s-0029-1185455

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  21 in total

1.  Bryonolic acid: a large-scale isolation and evaluation of heme oxygenase 1 expression in activated macrophages.

Authors:  Emily C Barker; Tonibelle N Gatbonton-Schwager; Yong Han; Jennifer E Clay; John J Letterio; Gregory P Tochtrop
Journal:  J Nat Prod       Date:  2010-06-25       Impact factor: 4.050

2.  Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.

Authors:  Sumana Dakeng; Suwit Duangmano; Weena Jiratchariyakul; Yaowalak U-Pratya; Oliver Bögler; Pimpicha Patmasiriwat
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

3.  Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.

Authors:  Tonibelle N Gatbonton-Schwager; John J Letterio; Gregory P Tochtrop
Journal:  J Nat Prod       Date:  2012-02-16       Impact factor: 4.050

4.  Effect of phytochemical intervention on dibenzo[a,l]pyrene-induced DNA adduct formation.

Authors:  Gilandra K Russell; Ramesh C Gupta; Manicka V Vadhanam
Journal:  Mutat Res       Date:  2015-02-25       Impact factor: 2.433

Review 5.  Use of cucurbitacins for lung cancer research and therapy.

Authors:  Min Liu; Qijia Yan; Bi Peng; Yuan Cai; Shuangshuang Zeng; Zhijie Xu; Yuanliang Yan; Zhicheng Gong
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-06       Impact factor: 3.333

Review 6.  Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer.

Authors:  Anupam Bishayee; Shamima Ahmed; Nikoleta Brankov; Marjorie Perloff
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

7.  De novo transcriptome analysis and identification of candidate genes associated with triterpenoid biosynthesis in Trichosanthes cucumerina L.

Authors:  Pornpatsorn Lertphadungkit; Xue Qiao; Supaart Sirikantaramas; Veena Satitpatipan; Min Ye; Somnuk Bunsupa
Journal:  Plant Cell Rep       Date:  2021-07-06       Impact factor: 4.570

8.  The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.

Authors:  Moltira Promkan; Sumana Dakeng; Subhas Chakrabarty; Oliver Bögler; Pimpicha Patmasiriwat
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

9.  A New Herbal Formula, KSG-002, Suppresses Breast Cancer Growth and Metastasis by Targeting NF- κ B-Dependent TNF α Production in Macrophages.

Authors:  Sang-Mi Woo; Youn Kyung Choi; Sung-Gook Cho; Sunju Park; Seong-Gyu Ko
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-30       Impact factor: 2.629

10.  Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.

Authors:  Suwit Duangmano; Phorntip Sae-Lim; Apichart Suksamrarn; Frederick E Domann; Pimpicha Patmasiriwat
Journal:  BMC Complement Altern Med       Date:  2012-10-12       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.